Regeneron Q3 earnings and revenues exceeded analyst estimates.
Context
What happened: Regeneron ($REGN) reported quarterly earnings of $20.07 per share and revenues of $5.12 billion, both beating the Zacks Consensus Estimate.
Key numbers: EPS $20.07 vs. estimate $16.08, a +24.81% surprise, and $11.83 a year ago. Revenue $5.12 billion vs. estimate beat of 12.43%, and $3.75 billion a year ago.
Why it matters: The company has topped consensus EPS and revenue estimates four times over the last four quarters. The article says near-term stock movement will depend mostly on management's commentary on the earnings call and on estimate revisions.
Market: +0.5% today ($82.70), +108.4% YTD, 1.0x vol — as of 22:46 UTC
Coverage: 7 outlets in 24h
Why it matters
The company has topped consensus EPS and revenue estimates four times over the last four quarters. The article says near-term stock movement will depend mostly on management's commentary on the earnings call and on estimate revisions.
Market: +0.5% today ($82.70), +108.4% YTD, 1.0x vol — as of 22:46 UTC